locally advanced malignant solid neoplasm
Showing 1 - 17 of 17
Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- Locally Advanced Malignant Solid Neoplasm
- Binimetinib
- +22 more
- (no location specified)
Dec 2, 2022
Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy,
Not yet recruiting
- Locally Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +5 more
- (no location specified)
Nov 8, 2022
Hematopoietic and Lymphoid System Tumor, Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in
Not yet recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +2 more
- Best Practice
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 29, 2022
Solid Tumors, Adult, PIK3CA Mutation-Related Tumors, PIK3CA Mutation Trial in San Francisco (Alpelisib, Carboplatin,
Not yet recruiting
- Solid Tumors, Adult
- +7 more
- Alpelisib
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 21, 2022
Adoption of Audio Recording in Outpatient Supportive Care Center
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +4 more
- Communication Intervention
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma
Recruiting
- Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
- +33 more
- Communication Intervention
- +2 more
-
New York, New York
- +3 more
Jun 29, 2022
Distress Associated With Coronavirus Disease 2019 and Telehealth
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +6 more
- Survey Administration
-
Houston, TexasM D Anderson Cancer Center
Jun 27, 2022
Locally Advanced Malignant Solid Tumor, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United
Recruiting
- Locally Advanced Malignant Solid Neoplasm
- +3 more
- Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949
- VLP-encapsulated TLR9 Agonist CMP-001
-
Scottsdale, Arizona
- +3 more
Jun 1, 2022
Locally Advanced Malignant Solid Tumor, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Solid Tumor Trial
Withdrawn
- Locally Advanced Malignant Solid Neoplasm
- +3 more
- (no location specified)
May 24, 2022
Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in San Francisco
Recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Support Group Therapy
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 12, 2022
Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Houston (Larotrectinib Sulfate)
Recruiting
- Locally Advanced Malignant Solid Neoplasm
- Metastatic Malignant Solid Neoplasm
- Larotrectinib Sulfate
-
Houston, TexasM D Anderson Cancer Center
Apr 18, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +129 more
- Cyclophosphamide
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Apr 8, 2022
Locally Advanced Malignant Solid Tumor Trial in Houston (Pembrolizumab)
Recruiting
- Locally Advanced Malignant Solid Neoplasm
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Mar 22, 2022
Advanced Malignant Tumor, ALK Fusion Protein Expression, ALK Gene Amplification Trial in Columbus (Brigatinib, Laboratory
Withdrawn
- Advanced Malignant Neoplasm
- +10 more
- Brigatinib
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 15, 2022
Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston
Active, not recruiting
- Locally Advanced Malignant Solid Neoplasm
- +2 more
- Pembrolizumab
- Pevonedistat
-
Houston, TexasM D Anderson Cancer Center
Jan 18, 2022
Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Locally Advanced Malignant Solid Tumor Trial run by the NCI (p97
Withdrawn
- Aggressive Non-Hodgkin Lymphoma
- +3 more
- p97 Inhibitor CB-5339 Tosylate
-
Bethesda, Maryland
- +1 more
Aug 27, 2021